Search Results
10
Everything
Search Filters
Tag
Biotech
Pharming Group to participate in April investor conferences
March 28, 2025 03:00 ET
|
Pharming Group N.V.
Leiden, the Netherlands, March 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor...
Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 27, 2025 16:05 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
NEC X Unveils Elev X! Ignite Batch 13: Six Disruptive Startups Driving Innovation in Fintech, AgTech, Lifesciences Tech and More
March 27, 2025 12:00 ET
|
NEC X
NEC X unveils Elev X! Ignite Batch 13, featuring six breakthrough startups driving global innovation through AI and advanced technologies.
SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer
March 27, 2025 08:00 ET
|
SpyGlass Pharma, Inc.
Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery Platform ALISO VIEJO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a...
Galatea Bio Secures $25M to Develop Global Biobank and Enable Precision Health at Scale for All
March 27, 2025 08:00 ET
|
Galatea Bio Inc
Galatea Bio Secures $25M to Develop Global Biobank and Enable Precision Health at Scale for All
Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors
March 27, 2025 07:00 ET
|
Quantum BioPharma
TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce the appointment of Terry...
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
March 26, 2025 17:05 ET
|
Abivax
Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France – March 26, 2025 – 10:05 PM CET – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or...
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
March 26, 2025 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
March 25, 2025 16:00 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through...
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity
March 25, 2025 09:00 ET
|
Helicore Biopharma
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity